BBT Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

BBT Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-50,000	Closed	-$2.51M	–	222
2015 Q1	$2.51M	Hold	50,000	–	–	0.26%	77
2014 Q4	$1.73M	Hold	50,000	–	–	0.14%	127
2014 Q3	$1.64M	Hold	50,000	–	–	0.09%	189
2014 Q2	$1.92M	Hold	50,000	–	–	0.12%	167
2014 Q1	$1.99M	Sell	50,000 -15,000	-23%	-$671K	0.09%	203
2013 Q4	$2.43M	Hold	65,000	–	–	0.11%	196
2013 Q3	$2.96M	Sell	65,000 -161,243	-71%	-$4.82M	0.15%	157
2013 Q2	$6.12M	Buy	+226,243	New	+$5.18M	0.32%	82

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BBT Capital Management's KYTH Position: Q2 2015 in Review

BBT Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2015, closing a stake of 50,000 shares — an estimated $2.51M sold.

BBT Capital Management first reported a position in KYTH in Q2 2013 and held it in 8 quarters. The position peaked at $6.12M in Q2 2013. 153 funds tracked by Wall St. Rank hold KYTH as of Q2 2015.

BBT Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2015 after selling out during the quarter.
BBT Capital Management sold 50,000 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2015, an estimated $2.51M.
BBT Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 8 quarters.
BBT Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $6.12M in Q2 2013.
153 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2015.

Based on BBT Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.